YILING PHARMACEUTICAL(SZ:002603) Zheng Quan Ri Bao·2025-12-09 10:17Group 1 - The Second China Respiratory Health Conference was held in Guangzhou, gathering over 1,200 experts and scholars in the field of respiratory diseases for academic exchanges [2] - Yiling Pharmaceutical showcased its innovative drug research results in the respiratory field and was granted membership in the "Traditional Chinese Medicine Respiratory Health Development Community" [2][9] - The conference marked the official launch of the "Traditional Chinese Medicine Respiratory Health Development Community" for 2026 [4] Group 2 - Academicians Zhang Boli and Zhong Nanshan visited Yiling Pharmaceutical's booth, where the company presented key respiratory products such as Lianhua Qingwen Capsules and Lianhua Qingke Tablets [3][6] - Lianhua Qingwen Capsules, an innovative drug for treating colds and influenza, has been included in the traditional Chinese medicine prevention and treatment plans in provinces like Shandong and Sichuan [3] - Yiling Pharmaceutical has established a unique development model based on the theory of network diseases, integrating theory, clinical practice, new drug development, industry, and education [6] Group 3 - The company is focusing on evidence-based medicine to validate the efficacy of traditional Chinese medicine, with over 120 SCI papers published on Lianhua Qingwen since its launch [6] - Yiling Pharmaceutical has built a comprehensive industrial capability, achieving standardized control from raw material planting to drug production and market circulation [6] - The company aims to actively participate in the community's initiatives, integrating internal and external resources for collaborative research and academic promotion in the respiratory health field [9][7]